An implant system that undergoes a gradual, time-dependent, nontoxic degradation process may offer an efficacious, safe, and desirable alternative to metallic materials used in the treatment of various musculoskeletal conditions. Such a scaffold may also be a suitable vehicle for growing cells and tissue in the laboratory for tissue engineering applications. We have used a scaffold of this type previously in animal studies for biological resurfacing of large articular cartilage defects.
INTRODUCTION K ULKARNI ET AL.
2 generated the initial interest in the use of polylactic acid (PLA) and polyglycolic acid (PGA) polymers in the field of medicine. Subsequently, biodegradable sutures made from PLA were used to repair mandibular fractures in dogs. 3 Since that time there has been an enormous amount of further research in this field. PLA and PGA are attractive for many reasons. They tend to "degrade" slowly, making them an attractive means for use in internal fixation. "Degradation" in this sense is used to denote mass loss due to resorption or dissolution of the biomaterial, precipitated or accompanied by molecular weight reduction, structural changes, and reduction in strength and stiffness. These materials provide a gradual transfer of loads to the healing tissues, greatly reducing the osteopenia commonly seen in hard tissues secondary to stress shielding by metallic implants. This slow transfer occurs because as the polymer degrades, its mechanical properties deteriorate. Thus, it can support a decreasing level of load resulting in a gradual increased loading of the healing tissue. Perhaps the greatest advantage of using biodegradable implants is that they bioabsorb in situ, making it unnecessary to perform a repeat surgical procedure for their removal. PLA and PGA are bioabsorbable polyesters belonging to the poly a-hydroxy acids group. 4 These polymers and their copolymers (hereafter referred to as PLG) degrade by nonspecific hydrolytic scission of their ester bonds. 5 The hydrolysis of PLA yields lactic acid, which is a normal byproduct of anaerobic metabolism in humans and is incorporated in the tricarboxylic acid (TCA) cycle to be finally excreted by the body as carbon dioxide and water. Polyglycolic acid biodegrades by a combination of hydrolytic scission and enzymatic (esterase) action producing glycolic acid, which can either enter the TCA cycle or is excreted in urine.
There has been a considerable amount of research performed in the field of polymer degradation. Polyglycolic acid implants in an in vivo study commenced hydrolysis within 2 days and their tensile strength was gradually reduced to zero within 28-32 days. 7 However, 100% PLA rods implanted in the medullary cavity of rabbits demonstrated a lengthy decline in molecular weight (MW) over a period of nearly 18 months. 8 An in vivo study comparing the degradation rates of various copolymers found that a 50:50 PLG copolymer with starting MW of 46 kDa degraded the fastest with a half-life of 1 week. 9 A recent in vitro study demonstrated that 50:50 PLG with an initial MW of 60 kDa completely degraded in a gradual fashion over a period of 10 weeks. 10 These studies suggest that there is a wide temporal range during which degradation occurs depending on the identity of the polymers involved.
It is well known that the characteristics and kinetics of PLG degradation are a function of monomer ratio, molecular linearity, initial MW, and percent crystallinity. Higher MW polymers take longer to degrade because the size of their molecular chains has to be reduced below a threshold level for the chains to acquire enough mobility to diffuse out of the system. 10 Furthermore, since PLG degrades by hydrolytic scission, more porous implants degrade faster as they offer a higher surface area for contact with water molecules. 10 It has also been shown that the rate of decrease in MW is directly proportional to the glycolic acid content of the polymeric implant. 7 Crystallinity plays a significant role in the rate of polymer degradation. Crystallinity is determined by the arrangement of the polymers' molecular chains and is affected by molecular chemistry, temperature, and rate of cooling during solidification from a melt. 4 Monomer units containing large or complex chemical species render crystalline order difficult to obtain. 4 On the other hand, elevated temperatures and a slow rate of cooling enable the chains to be mobile and to reposition themselves in a more ordered crystalline pattern. 4 Therefore, the crystallinity of PLG copolymers can be greatly altered as a result of changes in the fabrication process. PGA and L-PLA polymers are best described as being semicrystalline, since they contain both crystalline and amorphous regions. 1112 The ratio between crystalline and amorphous contents is an important determinant of degradation characteristics because crystallinity is inversely related to the rate of polymer breakdown. 13 Crystalline regions provide less access to water molecules than the amorphous regions and, as a consequence, are more resistant to hydrolysis.
As outlined above, the degradation of implants fabricated from PLG polymers occurs by a basic chemical phenomenon, but is rendered complex in nature due to the influence of a variety of interacting factors. These parameters depend not only on the chemical makeup of the polymer but also on the fabrication process to a significant degree. PLG implants can be fabricated using a variety of techniques; a comprehensive review of these has been provided by Agrawal et al. 14 The choice of a fabrication methodology can determine the molecular weight distribution, crystallinity, porosity, permeability, and mechanical properties of the implant. Each of these parameters, in turn, can influence the degradation characteristics of the implant.
The authors of the present study have previously described two-phase PLG implants, which could potentially be used for osteochondral repair. 115 The fabrication process for each of the two phases in these implants is different, leading to differences in their physical, mechanical, and morphological properties. Thus the objective of this study was to examine the degradation characteristics of the two phases and the composite two-phase implant. Changes in molecular weight, surface axial strain, and percent porosity were determined to better elucidate these objectives.
MATERIALS AND METHODS
The overall design objective of our ongoing research is to produce biodegradable implants that can be used to enhance tissue regeneration and repair processes in the treatment of osteochondral defects in di-50:50 PLA/PGA SCAFFOLD FOR TISSUE ENGINEERING arthrodial joints. To this end, the production methodology involves steps for making a two-phase implant with mechanical and physical characteristics that mimic those of cartilage and underlying bone at the site. For this study, a total of 180 implants were manufactured and divided equally into three groups: "bone" phase, "cartilage" phase, and two-phase implants. The initial dimensions of the implants were "bone" phase: 5 mm height X 7 mm diameter; "cartilage" phase: 2 mm height X 7 mm diameter; and two-phase: 7 mm height X 7 mm diameter. These implants were fabricated using 50:50 poly-D,L-lactide-co-glycolide (Birmingham Polymers, Birmingham, AL) with an inherent viscosity of 0.71 dl/g, polydisperity of 1.75, and initial weight average molecular weight of 54.5 kDa. To make the "bone" phase section of the 60 twophase implants, 4.5 g of copolymer was solubilized in 21.5 ml of acetone. This mixture was then mechanically stirred for 20 min to ensure that the polymer was completely dissolved in the acetone and then precipitated in 13.5 ml of 200 proof ethanol. The gummy composite was meticulously separated from the liquid phase and then manually kneaded to allow the escape of excess alcohol and acetone. It was then placed in a desiccator at room temperature for 5 min under 25 mTorr vacuum. The polymer was next flattened to an approximately 0.5-mm-thick film by rolling it with a 0.5-in.-diameter Teflon® (DuPont Chemical Company, Wilmington, DE) rod. The polymer was again placed in desiccator under 25 mTorr vacuum for 3 min. The film was then divided into 60 separate pieces of equal weight. These pieces were packed in a Teflon mold and resubjected to 25 mTorr vacuum at room temperature for approximately 22 min. Care was taken not to handle the polymer except to push any extruded amounts back into the mold. The mold was then placed in a lyophilizer under 37°C and 25 mTorr vacuum was applied for 2 h. It was then placed at room temperature and subjected to 25 mTorr pressure in a lyophilizer for 20 h. The implants were removed from the mold and placed in a vacuum oven at 47°C for 24 h. Thus, the 5 mm height X 7 mm diameter "bone" phase of the two-phase implants was produced. Subsequently, the "cartilage" phase was produced in a similar fashion. Following the flattening step with the Teflon® rod, the polymer was divided into masses of equal weight and placed into the Teflon® mold, forming the "cartilage" phase implants. Thus, the "cartilage" phase, unlike the "bone" phase, was not subjected to extensive vacuum or high temperature treatments. The two-phase implants were constructed by placing the "cartilage" phase on top of the "bone" phase. Although no additional adhesives, solvents, or other bonding elements were used in this process, the two phases stuck together due to the presence of organic solvents in the "cartilage" phase. The implants were then placed in a lyophilizer for 24 h and finally stored in a desiccator at room temperature until time of testing.
Sixty implants in each of the three groups ("bone," "cartilage," and two-phase) were studied for their degradation characteristics. Degradation was studied at t = 0, 2, 4, 6, and 8 weeks such that each time period contained 12 implants. The / = 0 week specimens served as the controls. Each implant was placed in a capped centrifuge tube containing 5 ml of phosphate-buffered saline (PBS) at pH 7.4 and 37°C. Every 3.5 days, the PBS solution was aspirated using a pipette and discarded. New 5 ml of PBS was then added. After each 2 week interval, 12 implants were removed and placed in a desiccator under 25 mTorr vacuum at room temperature until further testing.
To elucidate the kinetics of polymer degradation, changes in the implants' MW, compressive mechanical properties, percent porosity, and morphological structure were examined. Gel permeation chromatography (GPC) was used to determine temporal changes in weight average molecular weight. Specimens representing a cross section of the implant, approximately 3 mg in weight, were dissolved in 1 ml of chloroform. This solution was then filtered through a 0.45-^m filter and injected into the GPC system that used chloroform at 32°C as the mobile phase and polystyrene standards. Molecular weight was monitored up to t = 4 weeks.
The implants' mechanical behavior was determined using creep indentation measurements on an automated creep indentation machine. 16 The implant was attached to the specimen holder using cyanoacrylate. A fiberoptic laser positioning system was used to obtain perpendicular alignment of the test site. The test chamber was then filled with PBS and a tare load of 0.02 N was applied for 15 min. A step load of 0.083 N was then applied through a 0.5-mm-diameter, porous, rigid, indenter tip to obtain 1 h of creep. The surface axial strain at 1 h, <? zz s (z = 0, r = 0, t = 3600 sec) was calculated by normalizing the equilibrium creep value with each implant's thickness.
Scanning electron microscope (SEM) photographs at magnifications of 80-650X were taken of both the exterior (uncut) and interior (cut) surfaces of the "bone" phase, "cartilage" phase, and two-phase implants.
The cut surface of the implants was obtained by first placing the specimens in 5 ml of liquid nitrogen for 30 sec and then using a guillotine-like device to obtain a smooth, even cut through the implant interior. The SEM micrographs were then scanned into a computer. The boundaries of the pores were outlined using an image analysis software (NIH Image) and the total area encompassed by these pores was determined. This area was then divided by the total area of the SEM micrograph to calculate the percent porosity. For the two-phase implants, SEM micrographs of an area 0.5 mm above and below the interface line between the two phases were used for porosity measurements. For morphological examinations, 1:1 magnification photographs were taken at each time period to determine macroscopic and gross structural changes.
An effort was made to detect and measure the melting temperature (T m ) or any significant crystallinity in the implants using differential scanning calorimetry (DSC). The implant was cut into multiple small pieces and 3-5 mg of sample was then analyzed on the DSC system.
Surface axial strain, weight average molecular weight, and percent porosity values were compiled as mean ± standard deviation and were statistically examined with analysis of variance (ANOVA), multiple comparison tests, and Student's t test as required.
RESULTS
The results show significant temporal changes in both single-phase and two-phase implants. Figure 1 shows the change in surface axial strain for the "bone" and "cartilage" phase implants over a period of 4 weeks. There is a statistically significant decrease of approximately 65% in surface axial strain during the first 2 weeks in both groups of implants. This was followed by a significant increase to near initial values in the "bone" phase by 4 weeks. During the same period of time, the surface axial strain for the "cartilage" phase first decreased and then increased to approximately 230% of its initial value. Thus, both phases of the implant became stiffer by 2 weeks and then reversed the trend and became more compliant by 4 weeks. Changes in surface axial strain for "bone" phase and "cartilage" phase during the initial 4 weeks of testing in = 6 per group). "Bone" phase is significantly stiffer than "cartilage" phase at t = 0 and 2 weeks. Both groups experience an initial period of stiffening (decrease in surface axial strain) followed by gradual increase in compliance. A gradual, statistically significant decline in weight average molecular weight of the "bone" and "cartilage" phase implants occurred over a period of 4 weeks (Fig. 2) . The molecular weight of "bone" phase implants decreased from an initial value of 58 kDa at t = 0 weeks to 8 kDa at t = 4 weeks. Similar results were seen in the "cartilage" phase as the molecular weight decreased from 56 to 16 kDa over this same time period. DSC measurements on implants at t = 0 weeks indicated a low endothermic peak extending from approximately 90 to 120°C. However, no perceptible peak indicating a T m was observed up to 4 weeks.
The change in percent porosity over a period of 4 weeks on the uncut outer surface of the implants is shown in Figure 3 . This porosity was essentially zero at t -0 weeks for each of the 3 groups. There was a marked, statistically significant increase in percent porosity seen in "bone" (26%), "cartilage" (17%), and two-phase (32%) groups from t = 0 to t = 2 weeks. The percent porosity continued to increase even further in all 3 phases from t = 2 to t = 4 weeks. Figure 4 shows the change in percent porosity on the cut, interior surface of the 3 different groups of implants. At t = 0 weeks the initial percent porosity for the "bone" phase was 48.5%, "cartilage" phase 41%, and two-phase 50%. There was a statistically significant increase in percent porosity to 59% over the first 2 weeks in the "bone" phase. No significant changes were observed in percent porosity over the initial 2 weeks in either the "cartilage" or two-phase implants. In addition, there were significant differences between the "bone" and "cartilage" phase groups at t = 0 and t -2 weeks. Specifically, at t -0 the "bone" phase was 18% more porous than the "cartilage" phase. At t = 2 weeks and t = 4 weeks, the "bone" phase was 40 and 16% more porous, respectively, than the "cartilage" phase.
An SEM micrograph of the exterior surface of a "bone" phase implant at t -0 weeks is shown in Figure  5 . There are multiple linear markings visible on the surface but the number of pores is close to zero. Figure  6 shows the interior surface of a "bone" phase implant at t = 0 weeks. The pores are considerably increased in both number and size in the interior of the implant, compared to the exterior. Similar differences between the exterior and interior of the "bone" phase implant were seen at t = 2 weeks (Figs. 7 and 8 ). 3 . Percent porosity at the uncut, exterior surface is essentially zero at / = 0 weeks in "bone," "cartilage," and 2-phase implant groups (n = 3 per group). A marked, statistically significant increase in percent porosity is seen in the first 4 weeks within each of the 3 groups. In addition, "bone" phase is statistically more porous at the surface than the "cartilage" phase during the first 4 weeks.
The gross morphology of the "bone," "cartilage," and two-phase implants did not exhibit any significant differences. At t = 0, the implants were smooth, translucent, and had few surface irregularities. At t = 2 weeks, the implants were considerably harder to the touch and had changed to a bright, chalkish-white color. At t -4 weeks, the implant surface had more cracks and cavities but the overall structure was fairly well maintained. By / = 6 weeks, the implants had lost considerable structural composition and were extremely soft and malleable. Implants were almost completely disintegrated by t = 8 weeks.
DISCUSSION
This study focused on the examination of the salient degradation characteristics of a 50:50 PLG copolymeric implant proposed to be used for the treatment of osteochondral defects. One-phase ("bone" and "cartilage") and two-phase ("osteochondral") implants were studied until virtually complete degradation, which occurred by approximately 8 weeks. In summary, significant differences were found in the degradation characteristics of the "bone" phase and "cartilage" phase, suggesting that the fabrication methodology plays a pivotal role in determining this implant's functional behavior. Furthermore, it was shown that these 50:50 PLG implants degrade in a temporally biphasic manner with significant differences observed between the first 2 weeks and the remainder of the degradation process. Additionally, it was interesting to note vast differences between the surface and interior structural and degradation characteristics of these implants, suggesting that the presence of a relatively nonporous "skin" may significantly alter this implant's degradation kinetics and in vivo response.
The initial segment of degradation lasted from t = 0 to 2 weeks and consisted of a decrease in molecu-
E3 "BONE" lar weight, a decrease in surface axial strain, and an increase in percent porosity at both the outer and interior surfaces of the implants. A significant decrease in molecular weight of about 30% in "bone" phase and approximately 50% in "cartilage" phase was seen over the first 2 weeks of testing. In a study by Agrawal et al. 17 similar results were obtained as 50:50 PLG implants with an initial molecular weight of 71 kDa had a 34% decrease in molecular weight over 3 weeks. It has been reported that loss of molecular weight starts immediately upon contact with water accompanied by a simultaneous decrease in implant strength. 18 However, the decrease in surface axial strain in this study suggests a paradoxical increase in mechanical strength. An earlier study by Athanasiou et al. 10 hypothesized that this could be attributed to a possible increase in crystallinity of the polymer by breakdown of the chains in the amorphous regions. As the chains get smaller in size they increase in mobility and have a higher ability to crystallize. The DSC measurements in this study failed to detect a melting point during the first 4 weeks of testing. Coombes and Heckman 19 obtained similar DSC results for 50:50 PLG implants. They detected an increase in crystallinity only after 4 months of the degradation process under similar testing circumstances. This absence of a true melting point suggests that the polymer was mostly amorphous in nature and perhaps a reason other than, or in conjunction with, an increase in crystallinity was probably responsible for the decrease in surface axial strain. The increase in stiffness (both gross and mechanical) could be the result of a plasticization phenomenon from solvent trapping by the polymer. The percent porosity results for t -0 weeks support this hypothesis because there was high porosity within the implant interior (48.5% for "bone" phase, 41% for "cartilage" phase) but minimal porosity (3.3% for "bone" phase, 0% for "cartilage" phase) at the implant surface. Thus, solvent could have easily been retained within the implant interior during the fabrication process. In addition, the presence of short chain oligomers could also have resulted in a plasticization process. Further studies need to be conducted to better elucidate the intricacies of this finding.
The degradation process from t = 2 to 4 weeks involved a continuous decrease in molecular weight coupled with an increase in surface axial strain. The molecular weight decreased by 87 and 67% of initial values by the end of 4 weeks for "bone" phase and "cartilage" phase, respectively. Percent porosity for both phases increased on the exterior surface, but remained approximately constant in the interior. In addition, it is in this time period that the implants began to lose their structural properties. This process continued for the remainder of the testing duration and the implants were nearly completely disintegrated by 8 weeks. While we did not document changes in material weight in this study, our previous studies suggest that significant mass loss of a similar implant does not occur until after 3^4 weeks of testing. 20 This decline in material weight corresponds to the initial loss of structural properties as seen in this study at around 4 weeks.
It has been reported that degradation of PLG implants initially occurs faster at the center than at the surface of the implant due to entrapment of degradation products. 2021 The results obtained in this study showed the presence of a "skin" on the implants' surface, which may contribute to this phenomenon. SEM micrographs at t = 0 weeks showed almost no porosity at the surface of the implants, while the interior was filled with multiple pores allowing rapid hydrolysis to occur at the center. These initial physical characteristics of the implant (low percent porosity at the surface) and high molecular weight of the chains (responsible for steric effects) resulted in a "skin" phenomenon, preventing degradation products generated at the center of the implant from readily exuding. The exterior surface of the implant may have also provided a barrier between the vastly different internal and external degradation milieus. However, continued degradation resulted in increased percent porosity and decreased molecular weight and a gradual loss of this "skin" bar-205 rier. Once a threshold value was reached there was rapid, generalized decrease in both material and structural properties of the implant.
Considerable differences were present in the degradation characteristics of "bone" phase vs. "cartilage" phase implants, probably as a result of differences in the fabrication processes. The "bone" phase was significantly stiffer compared to the "cartilage" phase at t = 0 and 2 weeks. However at t = 4 weeks, both phases exhibited similar stiffness. Although the molecular weights of the two phases were similar initially, significant differences were observed in the temporal decreases of molecular weight at t = 2 and 4 weeks. For example, at t = 2 weeks, the molecular weight of "bone" phase was 30% greater than that of the "cartilage" phase. In contrast at / = 4 weeks, the molecular weight of "bone" phase was 50% less than that of the "cartilage" phase. The percent porosity of the "bone" phase was significantly greater than that of the "cartilage" phase at all time groups and is probably secondary to differences in the fabrication process. The complex interplay between changes in stiffness, molecular weight, and percent porosity resulted in the various degradation outcomes and patterns seen in this study.
Our goal in this study is to design an osteochondral implant with the "bone" phase similar to underlying cancellous bone and "cartilage" phase similar to articular cartilage for use in the repair of osteochondral defects. The results obtained suggest that as in cancellous bone and articular cartilage, the "bone" phase was stiffer and more porous than the "cartilage" phase. Additional work needs to be performed to make the "bone" phase even stiffer and to match the permeability values of the two phases to those of cartilage and bone. In conclusion, this particular implant may offer a new method for the treatment of various musculoskeletal conditions, such as in biological resurfacing of large articular cartilage defects.
